John T. Henderson, Director at CYTOKINETICS INC (CYTK), sold 21,124 shares at $64.54 ($1.4M) on 2024-04-25, disclosed to the SEC on 2024-04-25.
Scheduled sale ($1.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.54 | 10,562 | $682K | 50.0% |
| 2 | $64.54 | 10,562 | $682K | 50.0% |
| Total | $64.54 avg | 21,124 | $1.4M | 100% |
| Filing → |
| CYTK | SELL | 2025-04-16 | $247K | — | Filing → |
| CYTK | SELL | 2024-12-12 | $179K | — | Filing → |
| CYTK | SELL | 2024-02-14 | $382K | — | Filing → |